Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Sanofi India Ltd (Sanofi India), a subsidiary of Sanofi, is a healthcare company that develops and distributes prescription medications and vaccines. It offers pharmaceutical products, including teriflunomide tablets, ramipril and atorvastatin tablets, skin cream, teicoplanin, telmisartan and amlodipine tablets, telmisartan, amlodipine and hydrochlorothiazide tablets, controlled release tablets of sodium valproate and valproic acid, sodium valproate, teicoplanin, telmisartan and amlodipine tablets, sodium valproate, poliomyelitis vaccine, among others. Sanofi India's products are applied across various medical fields such as oncology, neurology, and endocrinology. The company markets its products under the brands Cerezyme, Aldurazyme, Myozyme, Fabrazyme, Lemtrada, Aubagio, Jevtana, Stamaril, Vaxigrip, Tetraxim, and others. Sanofi India is headquartered in Mumbai, Maharashtra, India.
Headquarters
India
Address
Sanofi House, CTS No.117-B, Saki Vihar Road, L and T Business Park, Powai, Mumbai, Maharashtra, 400072
Website
www.sanofi.com/en/india
Telephone
91 22 28032000
No of Employees
871
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
SANOFI (NSE)
Revenue (2024)
$210.9M
-8.7%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-21%
(2024 vs 2023)
Market Cap*
$759.2M
Net Profit Margin (2024)
XYZ
-13.4%
(2024 vs 2023)
* As of and is in US$
Sanofi India Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pipeline | Aldurazyme |
| Pharmaceutical | AllStar |
| Laronidase solution for injection | Amaryl |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In July, the company partnered with Emcure Pharmaceuticals Ltd to broaden the reach of Sanofi's oral anti-diabetic drugs. |
| 1956 | Incorporation/Establishment | The company was founded. |
Competitor Comparison
| Key Parameters | Sanofi India Ltd | Aurobindo Pharma Ltd | Torrent Pharmaceuticals Ltd | Strides Pharma Science Ltd | GlaxoSmithKline Pharmaceuticals Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Mumbai | Hyderabad | Ahmedabad | Bengaluru | Mumbai |
| State/Province | Maharashtra | Telangana | Gujarat | Karnataka | Maharashtra |
| No. of Employees | 871 | 9,107 | 17,320 | 3,301 | 3,113 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Rachid Ayari | Director; Chief Financial Officer | Executive Board | 2023 | - |
| Rodolfo Hrosz | Executive Director; Director | Executive Board | - | - |
| Renee Viswonath Amonkar | Executive Director; Director | Executive Board | - | - |
| Haresh Vala | Chief Compliance Officer; Company Secretary | Senior Management | 2025 | - |
| Yasmin Shenoy | Senior Director- Regulatory Affairs | Senior Management | 2013 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer